Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm

Br J Haematol. 2012 Jan;156(1):118-28. doi: 10.1111/j.1365-2141.2011.08923.x. Epub 2011 Nov 14.

Abstract

In a study conducted on 114 patients undergoing unrelated donor haematopoietic stem cell transplantation (HSCT) for thalassaemia, we observed that the lack of activating killer immunoglobulin-like receptors (KIRs) on donor natural killer (NK) cells significantly increased the risk of graft-versus-host disease (GvHD) [hazard risk (HR) 4.2, 95% confidence interval (CI) 1.7-10.1, P = 0.002] and transplantation-related mortality (HR 4.7, 95% CI 1.6-14.2, P = 0.01). The risk of GvHD furthermore increased when recipients heterozygous for HLA-C KIR ligand groups (C1/C2) were transplanted from donors completely lacking activating KIRs (HR 6.1, 95% CI 1.9-19.2, P = 0.002). We also found that the risk of rejection was highest when the recipient was homozygous for the C2 HLA-KIR ligand group and the donor carried two or more activating KIRs (HR 6.8, 95% CI 1.9-24.4, P = 0.005). By interpolating the number of donor activating KIRs with recipient HLA-C KIR ligands, we created an algorithm capable of stratifying patients according to the immunogenetic risk of complications following unrelated HSCT. In clinical practice, this predictive tool could serve as an important supplement to clinical judgement and decision-making.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Algorithms*
  • Child
  • Child, Preschool
  • Female
  • Gene Frequency
  • Genotyping Techniques
  • Graft vs Host Disease / etiology
  • Graft vs Host Disease / genetics
  • Haplotypes
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Histocompatibility Antigens Class I / genetics*
  • Histocompatibility Antigens Class I / immunology
  • Histocompatibility Testing
  • Humans
  • Infant
  • Ligands
  • Male
  • Middle Aged
  • Models, Statistical
  • Prognosis
  • Protein Binding / immunology
  • Receptors, KIR / genetics*
  • Receptors, KIR / immunology
  • Retrospective Studies
  • Thalassemia / diagnosis
  • Thalassemia / genetics*
  • Thalassemia / therapy*
  • Unrelated Donors
  • Young Adult

Substances

  • Histocompatibility Antigens Class I
  • Ligands
  • Receptors, KIR